Pyxis Oncology reports Q2 2026 results, advances MICVO milestones
Pyxis Oncology (PYXS) reports second-quarter 2026 financial results and says it is advancing MICVO toward key 2026 clinical milestones, according to the company release.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.